ADHD and Addiction: Why They Co-Occur and How Treatment Works
Plain, fact-first answers about how care works here. Want to talk to a person? Call (888) 464-2144.
- The Archangel Centers is a licensed outpatient addiction treatment provider.
- The Archangel Centers operates clinics in Tinton Falls, NJ and Charlotte, NC.
- ADHD with co-occurring substance use disorder is part of the outpatient continuum at The Archangel Centers.
- ADHD and substance use disorder are treated together in an integrated dual-diagnosis treatment plan.
- Integrated dual-diagnosis care is delivered by the same clinical team from intake.
- Medication-assisted treatment (MAT) includes Suboxone, Vivitrol, and Sublocade.
- The Archangel Centers works with most major commercial insurance plans with free benefits verification.
Attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD) co-occur at rates that are too high to be coincidence. Adults with ADHD are roughly twice as likely to develop a substance use disorder during their lifetime as adults without it, and somewhere between a quarter and a half of adults in SUD treatment screen positive for ADHD. The two conditions share neurobiology: both involve dopamine reward circuitry, both involve weak impulse control, and both respond to the immediate relief that alcohol, cannabis, nicotine, or stimulants can offer.
This page is informational. It explains what adult ADHD is, why it travels so often with substance use, what the warning signs look like, why a substance-only program tends to fail ADHD-positive clients, and what evidence-based integrated treatment includes. If you are looking for treatment, see levels of care explained or call (888) 464-2144 to speak with admissions at The Archangel Centers.
What adult ADHD is
In the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), the American Psychiatric Association defines ADHD as a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development, with symptoms present before age twelve and across more than one setting. The diagnosis is not a childhood diagnosis only. Most children with ADHD continue to meet criteria, in modified form, into adulthood, and the National Institute of Mental Health estimates adult ADHD prevalence in the United States at roughly 4.4 percent.
DSM-5 identifies three presentations:
- Predominantly inattentive presentation: difficulty sustaining attention, careless mistakes, trouble organizing tasks, easily distracted, forgetful in daily activities, avoidance of work that requires sustained mental effort
- Predominantly hyperactive/impulsive presentation: restlessness, fidgeting, difficulty waiting, interrupting, talking excessively, acting without thinking
- Combined presentation: meaningful symptoms from both clusters
How ADHD presents differently in adults
Pediatric ADHD is often visible from the outside: the child who cannot sit still, the child who blurts out answers, the child who loses homework. Adult ADHD frequently looks different. Hyperactivity often turns inward, showing up as restlessness, racing thoughts, or chronic overcommitment rather than physical motion. Inattention shows up as missed deadlines, half-finished projects, chronic lateness, forgotten bills, and a working life that feels harder than it should. Impulsivity shows up in spending, in interpersonal conflict, in driving, in substance use, and in decisions that look careless to others but feel, in the moment, like the only available option.
Adults with ADHD often describe a lifetime of feeling like they are working twice as hard for the same result, of being told they are smart but unfocused, and of using whatever they can find — caffeine, nicotine, cannabis, alcohol, stimulants — to bridge the gap between what their attention can do and what their life requires.
How ADHD and substance use interact
ADHD substantially raises lifetime risk of substance use disorder. Population studies consistently put the rate of SUD among adults with ADHD at two to three times the rate in the general population, and studies of adults in addiction treatment find ADHD in roughly 25 percent or more of cases — about five times the population base rate. The relationship is not a coincidence; it has several converging causes.
The first is the self-medication hypothesis. People with untreated ADHD frequently report that certain substances quiet the noise. Stimulants such as cocaine, methamphetamine, and misused prescription stimulants can temporarily improve focus and energy. Nicotine sharpens attention in the short term. Alcohol and cannabis can dampen restlessness, slow racing thoughts, and help with sleep. These effects are real in the moment and devastating over time, because they ride on substances that are addictive, escalating, and damaging to the underlying neurobiology.
The second is shared reward circuitry. ADHD involves dysregulation of the dopamine system, which is the same system addictive substances hijack. A brain that under-responds to ordinary rewards is a brain that is unusually sensitive to the supraphysiologic dopamine release from alcohol, cocaine, opioids, and other drugs. The relief is bigger, and the pull back is stronger.
The third is impulsivity. Substance use decisions are, in part, impulse-control decisions: continuing past a planned stopping point, using when stressed, relapsing on a difficult day. ADHD weakens the executive systems that interrupt those impulses, which is part of why ADHD-positive clients in SUD treatment without ADHD treatment relapse at higher rates than their peers.
Signs and symptoms of co-occurring ADHD and SUD
No single symptom diagnoses co-occurring ADHD and SUD. A clinician puts the pattern together. Common signs in adults include:
- Lifelong difficulty with focus, organization, time management, or follow-through that predates the substance use
- Substance use that began earlier than peers, often in adolescence
- A pattern of using stimulants, nicotine, caffeine, or cannabis to function rather than to party
- Using alcohol or cannabis at night to slow down, sleep, or quiet racing thoughts
- Impulsive use: starting without planning, using more than intended, escalating quickly
- Repeated promises to cut back, followed by impulse-driven returns to use
- Missed appointments, missed work, missed treatment sessions
- Emotional dysregulation: short fuse, intense reactions, difficulty returning to baseline
- Academic or occupational underachievement relative to apparent ability
- Childhood history of ADHD diagnosis or symptoms, even if never formally treated
Why a substance-only program fails ADHD-positive clients
Standard substance use disorder treatment is built around skills: identifying triggers, planning around them, attending groups consistently, completing assignments, calling a sponsor before using. Each of those skills relies on the same executive functions that ADHD impairs — sustained attention, task initiation, working memory, planning, and impulse control. When ADHD is undiagnosed or untreated, clients miss sessions, lose worksheets, fall behind in groups, fail to call before using, and relapse in ways that get misread as motivation problems rather than what they actually are: executive function gaps.
The data is consistent. ADHD-positive clients in SUD treatment without integrated ADHD care have higher dropout, lower retention, and higher relapse rates than ADHD-negative peers. They also frequently get labeled by treatment teams as resistant or non-compliant, when the underlying issue is that the program is asking them to use the exact skills their condition impairs. Treating SUD without treating ADHD is treating half of the case.
Treatment levels of care
Evidence-based treatment is matched to severity. The American Society of Addiction Medicine (ASAM) describes a continuum that scales from outpatient counseling to medically managed inpatient care. For co-occurring ADHD and SUD, the structured outpatient continuum is often a particularly good fit, because the daily clinical day delivers what many adults with ADHD struggle to build on their own: external structure.
The most common outpatient levels:
| Level | What it looks like | Who it's for |
|---|---|---|
| Outpatient (OP) | Individual therapy, periodic groups | Mild presentations, or step-down from a higher level |
| Intensive Outpatient (IOP) | 3 or 5 days per week, 3 clinical hours each | Moderate co-occurring ADHD and SUD, or step-down from Partial Care |
| Partial Care / Day Treatment | Full clinical day, 5 or 6 days per week | Severe co-occurring presentations, significant functional impairment, or step-down from detox |
| Virtual Treatment | Same programming via secure video | New Jersey residents whose home environment supports remote care |
| Medical Detox / Inpatient | 24-hour monitoring at a partner facility | Active withdrawal management, then step-down into outpatient |
Why structure helps
The Partial Care / Day Treatment format runs a planned curriculum across the clinical day, with arrival, groups, individual time, and a defined end. That external scaffolding takes pressure off the internal executive systems that ADHD impairs, and it is part of why many ADHD-positive clients respond better to a higher-intensity outpatient track than to a thinly scheduled outpatient one. The Archangel Centers does not provide medical detox or inpatient rehabilitation on-site; those levels are coordinated with accredited partner facilities. See medical detox in Tinton Falls for how that handoff works.
Therapy approaches with the strongest evidence
Several therapy modalities have well-documented effectiveness for co-occurring ADHD and SUD. Effective programs combine them rather than pick one.
- Cognitive behavioral therapy (CBT) adapted for ADHD builds externalized planning, task-initiation, and organization skills, alongside the trigger-identification and coping work that standard SUD CBT covers. See CBT for addiction.
- Dialectical behavior therapy (DBT) skills, especially distress tolerance and emotion regulation, give clients concrete tools for the emotional dysregulation that ADHD frequently brings. Mindfulness skills help with the racing-thoughts pattern that drives evening alcohol or cannabis use.
- Motivational interviewing (MI) supports medication adherence and engagement decisions, both of which are particularly important when impulsivity and forgetting are part of the clinical picture.
- Behavioral activation pairs valued activities with daily routines, building structure around recovery rather than asking the client to generate it from scratch.
- Organization and planning skills training is an ADHD-specific protocol with growing evidence in adults, covering calendar use, task lists, time estimation, and follow-through systems.
- Trauma-informed care is integrated into individual therapy when trauma is part of the clinical picture, since trauma frequently co-occurs with both ADHD and SUD.
Medication considerations
Medication for adult ADHD in a client with substance use history is one of the more nuanced decisions in dual-diagnosis care. It is also one of the most consequential, because untreated ADHD is itself a strong driver of relapse.
Stimulant medications (methylphenidate and amphetamine-class) are the most-studied and most-effective treatments for adult ADHD. They are also controlled substances with misuse and diversion potential, which is why prescribing them in a client with active or recent SUD requires care: extended-release formulations rather than immediate-release, careful dose titration, monitored refills, and ongoing coordination between the prescribing provider and the SUD treatment team. The clinical evidence is that, when monitored, stimulant treatment of ADHD in patients with co-occurring SUD does not increase substance use risk and may reduce it.
Non-stimulant options are appropriate in many cases and carry no controlled-substance considerations. Atomoxetine (Strattera) is FDA-approved for adult ADHD. Bupropion has evidence for ADHD symptom reduction and is sometimes useful when depression or nicotine use is also part of the picture. Alpha-2 agonists such as guanfacine extended-release are an option, particularly when sleep, agitation, or anxiety are prominent.
Medication decisions are made collaboratively between the client and the on-site medical provider, after individual evaluation. The Archangel Centers' SUD medication-assisted treatment formulary covers Suboxone (buprenorphine/naloxone, primary for opioid use disorder), Vivitrol (long-acting naltrexone, for opioid or alcohol use disorder), and Sublocade. Methadone is not in the formulary; clients best served by methadone are referred to a federally licensed opioid treatment program. For stimulant use disorder, there is no FDA-approved MAT comparable to the opioid options, and behavioral interventions remain the primary evidence-based path.
What recovery from co-occurring ADHD and SUD looks like
Recovery from co-occurring ADHD and substance use is not a switch that flips. It is a slow build of external structure that compensates for the internal structure ADHD weakens, paired with treatment of the substance use and, where indicated, medication for the ADHD itself. The work is concrete: calendars that are actually checked, routines that survive disruption, sleep that holds, a network of people who know what is going on, and a treatment team that the client can stay connected to over months and years rather than weeks.
What predicts a sustainable recovery:
- Treatment that addresses ADHD and SUD together, in one plan, by the same team
- Programming matched to severity — a structured day for clients who cannot yet build structure on their own
- A clear, individualized medication decision made with full information rather than ideology
- External supports — calendars, alarms, accountability partners, daily routines — built and maintained as part of the recovery skill set
- Continued treatment past the acute phase: stepping down through IOP, then OP, then alumni connection, rather than stopping at the first sign of stability
- Time. Brain healing takes months. Executive-function rebuilding takes longer.
Frequently Asked Questions
How do I know I need ADHD and addiction treatment?
Will I need ADHD medication?
What if I have stimulant use disorder?
Will treatment interfere with work?
What if I'm suicidal?
What about hospitalization?
Can family participate?
Do you treat ADHD without SUD?
Is methadone available?
How long is treatment?
Admissions are confidential and staffed 24/7 at (888) 464-2144. Or browse a specific clinic page for hours, address, and the full program.